International Scleroderma Network
Skip to Page Content
Scleroderma from A to Z by the nonprofit International Scleroderma Network
The #1 scleroderma site with 2,000+ pages in 22 languages:
Arabic  Chinese  Deutsche/German  English  Español  Français  Greek  Hebrew  Hungarian  Indonesian  Italiano  Japanese  Kannada  Korean  Magyarul  Malaysian  Nederlands  Polski  Português  Romana  Russian  Spanish  Tamil  Turkish  Worldwide Lists
 
Earl's Running for SCLERO.ORG!
Sponsor Earl Manns in Green Bay Marathon, May 18, 2008! I'm running in honor of my daughter Mya, and in memory of Sherrill Knaggs. Join the excitement! (Also see: Donate Now, Earl Manns: ISN Fundraiser, and In Memory of Sherrill Knaggs)

Localized Scleroderma: Morphea
What is Morphea?
Complications of Morphea
Associated Conditions
Causes of Morphea
Rare Types of Morphea
Generalized Morphea
Keloid Morphea
Morphea Profunda
Pansclerotic Morphea
Diagnosis of Morphea
Treatments for Morphea
Morphea Patient Stories
English, Español, Italiano
See Also
U.S. Morphea Registry and DNA Repository
What is Morphea?
The most important thing to know about morphea is
that it is very different from the systemic forms of scleroderma, and it is never fatal.
Morphea Scleroderma on LegMorphea scleroderma and its variants are also known as atrophoderma of Pasini and Pierini, bullous morphea, circumscribed scleroderma, deep morphea, disabling pansclerotic morphea, en coup de sabre, eosinophilic fasciitis, generalized morphea, guttate morphea, keloid, keloidal, or keloid-like morphea, linear morphea, localized scleroderma, morphea profunda, nodular morphea, pansclerotic morphea, plaque-type morphea, progressive hemifacial atrophy, progressive facial atrophy, Parry Rombergs, Shulman's syndrome, and subcutaneous morphea.
When any form of scleroderma begins during childhood, it is called juvenile scleroderma. (Also see: Types of Scleroderma)
Morphea scleroderma usually begins as patches of yellowish or ivory-colored rigid, dry skin. These then become hard, slightly depressed, oval-shaped plaques which usually have a whitish or yellowish center surrounded by a pinkish or purplish halo.
Morphea is most commonly found on the trunk, but can occur anywhere on the body. About 75% of the time it affects only the skin or underlying muscles and joints.
Morphea Includes background, pathophysiology, frequency, mortality/morbidity, physical findings, causes, and treatments. emedicine dermatology.
Morphea, also known as localized scleroderma, is a disorder characterized by thickening and induration of the skin and subcutaneous tissue due to excessive collagen deposition. Morphea subtypes are classified according to their clinical presentation and depth of tissue involvement; they include plaque-type, generalized, linear, and deep varieties. eMedicine 2003.
Complications of Morphea
Plaque-type scleroderma associated with linear and oesophageal features and facial and extra-facial hemiatrophy. The combination of several sub-types of scleroderma and facial and extra-facial hemiatrophy in the same patient may indicate that these entities actually represent different spectra of the same disease. PubMed. Ann Dermatol Venereol. 2007 Jan;134(1):68-71. (Also see: Linear Scleroderma)
Morphea of the breast. Two case reports Morphea is a recognised sequelae of radiotherapy which should be distinguished from sclerotic recurrence of the original tumour. Surgical excision is possible in certain patients. PubMed. J Plast Reconstr Aesthet Surg. 2006;59(10):1114-7.
Postirradiation morphea in a breast cancer patient. It is important to be aware of this rare complication of radiation therapy because it clinically presents with symptoms mimicking malignancy and may be misinterpreted as recurrent carcinoma or even angiosarcoma. PubMed. Breast J. 2006 Mar-Apr;12(2):173-6. (Also see: Cancer and Scleroderma)
Scleroderma: a case report of possible cause of restricted movement of the temporomandibular joint with effects on facial development. Localized scleroderma is often benign, but may cause significant deformity, if it occurs on the face or extends across joint surfaces. Structural changes may occur in the osseous tissue and result in mandibular joint restriction (pseudoankylosis) and facial and occlusal disharmonies. PubMed. J Clin Pediatr Dent. 2003 Fall;28(1):33-8. (Also see: Linear, and Dental Involvement)
Associated Conditions
Overview of Associated Conditions
Additional Symptoms
Autoimmune Conditions
Cancer: T-Cell Lymphoma
Infections
Melanonychia
Skin Conditions
Systemic Scleroderma
Causes of Morphea
Cancer, Lymphoma
Dendritic Cells
Genetics
Infections
Borrelia Burgorferi
HTLV-1 Infection
Toxoplasma Gondii
Medications
Valproic Acid
Radiation
Solvents, Organic Solvents
Tumor Necrosis Factor (TNF)
Vitamin B12
Rare Types of Morphea
Bullous Morphea
Deep Morphea
Dermatitis Artefacta
Generalized Morphea
Guttate Morphea
Keloid Morphea
Morpheaform or Basal Cell
Morphea Profunda (Subcutaneous)
Pansclerotic Morphea
Generalized Morphea
Overview of Generalized Morphea
Symptoms of Generalized Morphea
Photos of Generalized Morphea
Treatments for Generalized Morphea
Causes of Generalized Morphea
Personal Stories
Keloid Morphea
Overview: What are Keloids?
Causes of Keloids
Diagnosis of Keloidal Scleroderma
Treatments for Keloids
Personal Stories
Morphea Profunda
Rare Types of Morphea: Profunda. ISN.
Pansclerotic Morphea
Overview of Pansclerotic Morphea
Symptoms of Pansclerotic Morphea
Treatments for Pansclerotic Morphea
Squamous Cell Carcinoma
Causes of Pansclerotic Morphea
Case Reports
Diagnosis of Morphea
Morphea is usually diagnosed by clinical examination. It is often confirmed by skin biopsy. Skin biopsies are usually a very tiny sample of tissue and the procedure is often very quick, easy and with minimal discomfort. Ultrasound has also been found to be useful for the diagnosis of Localized Scleroderma (such as morphea).
ISN Photo Repository: Morphea Photos. ISN.
A new computerized method for the assessment of skin lesions in localized scleroderma (LS). CSS (computerized skin score) has shown to be a reliable method to assess the skin lesions in patients with LS. It is reproducible, easy to use and, with the support of the CSS software, applicable worldwide. PubMed. Rheumatology (Oxford). 2007 Jan 30. (Also see: Localized Scleroderma:Linear)
Rheumatoid factor isotypes in localized scleroderma. The presence of RF isotypes is one of the immunological abnormalities of localized scleroderma. IgM RF seemed to be most useful of these three factors to determine the severity of disease. PubMed. Clin Exp Dermatol. 2005 Jul;30(4):405-8.
Juvenile-onset localized scleroderma activity detection by infrared thermography. Our results demonstrate that thermography is a promising diagnostic tool when associated with clinical examination in discriminating disease activity, as long as it is applied to lesions without severe atrophy of the skin and subcutaneous fat. Rheumatology (Oxford) 2002 Oct;41(10):1178-1182. PubMed.
Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Thirteen-megahertz ultrasound is a valuable tool for diagnosing LS. Morphological ultrasound diagnostic criteria had a high specificity and a high sensitivity. PubMed. Br J Dermatol 2003 Apr;148(4):724-9. (Also see: Linear)
Antiphospholipid antibody in localised scleroderma. These results suggest that aCL (antibodies against cardiolipin) and LAC (lupus anticoagulant) are the major autoantibodies in patients with generalised morphoea. PubMed. Ann Rheum Dis. 2003 Aug;62(8):771-4. (Also see: Antiphospholipid Syndrome and Antibodies)
Anti-DNA Topoisomerase II Alpha Autoantibodies in Localized Scleroderma. The present results indicate that anti-topo II alpha Ab is a major autoantibody in LSc, which is distinct from anti-topo I Ab in SSc. Ikuko Hayakawa. ACR Conference Oct. 2003 (Also see: Localized Scleroderma: Linear; and Antibodies)
Serum levels of manganese superoxide dismutase in patients with localized scleroderma. The results suggested that the serum levels of this enzyme may be a serological marker for the disease activity and the extent of skin involvement in this disease. PubMed. Exp Dermatol. 2004 Jun;13(6):357-60.
Treatment of Morphea
Overview
Scleroderma Experts
Apligraf for Bullous Ulcers
Calcipotriol Cream
Endermology or LPG
Imiquimod Cream
Laser
Methotrexate and Glucocorticoids
Phototherapy, UVA, PUVA
Tacrolimus Cream
English Morphea Patient and Caregiver Stories
Morphea Patient and Caregiver Stories (Main Listing). ISN.
Italian Morphea Patient and Caregiver Stories
Sclerodermia dalla A alla Z: Morphea Storia. ISN.
Spanish Morphea Patient and Caregiver Stories
La Esclerodermia desde la A hasta la Z: Morfea Historia. ISN.
See Also
Juvenile scleroderma. Scleroderma is a relatively rare disorder in children. Among its subsets, localized scleroderma is more common in children than the systemic variety. Curr Opin Rheumatol 2002 Sep;14(5):553-61,PubMed.
Atrophoderma of Pasini and Pierini (APP) is similar to Morphea Scleroderma. Some doctors think it represents a late-stage Morphea. ISN.
Diseases Similar to Scleroderma. ISN.
Juvenile Scleroderma. ISN.
Lichen Sclerosus. ISN.
Scleroderma Photos. ISN.
Skin Rashes and Other Changes. The location, appearance and color of a rash will help your doctor make the diagnosis. Look for care suggestions on this chart for common rashes. familydoctor.org.
References
[1] Morphea: Clinical History. Occasionally, localized morpheic lesions occur in the uninvolved skin of patients with systemic sclerosis. Morphea has also been reported in association with systemic lupus erythematosus, primary biliary cirrhosis, pemphigus, and dermatomyositis. eMedicine.com. (Also see: Systemic Scleroderma, Lupus, Primary Biliary Cirrhosis, and Dermatomyositis.)
[2] Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Children and adults developed LS with analogous clinical and immunological features. However, the prevalence of LS variants differed between adult and pediatric populations, leading to different extracutaneous complications. Among adults, Raynaud's phenomenon was found in 8 patients; interestingly, anticentromere antibodies were detected in 4 of these subjects, identifying a subset at risk for progression to systemic disease. PubMed. Eur J Dermatol 2003 Mar-Apr;13(2):171-6. (Also see: Raynaud's and Linear Scleroderma)
[3] Is Juvenile Localized Scleroderma really "LOCALIZED"? One fourth of JLS patients in this data series presented various kind of extra-cutaneous manifestations, sometimes with multiorgan involvement. For this reason, the term "localized" is somehow inappropriate. These findings should change our clinical approach to this disease and underline the need for systemic immunosuppressive treatment for some patients. Francesco Zulian. ACR Conference Oct. 2003. (Also see: Linear)
U.S. Morphea Registry and DNA Repository
First U.S. Morphea Registry and DNA Repository for both Adults and Children Established. Dermatologists at University of Texas Southwestern Medical Center are establishing a DNA repository aimed at people with morphea. They will collect information about other health conditions present, collect information about family history, and collect blood and skin samples to further define the genes associated with morphea and the genetic faces of morphea. Southwestern Medical Center. 05/31/07.
Keep on Surfing!
Go to CREST Scleroderma
Contact ISN
Email Postal Mail Phone
Inquiry Form (English) Mail-In Donation/Order Form Online Donation/Order Form
Inquiry Form (Spanish) Website: www.sclero.org Please contact us in English.
Email:
isn@sclero.org
webmaster@sclero.org

Or post a message in ISN's Sclero Forums for free well-moderated support and information, 24 hours a day!
International Scleroderma Network
7455 France Ave So #266
Edina, MN 55435
USA
Toll Free Hotline in U.S.
1-800-564-7099

Direct Line 1-952-831-3091
Arranging a Memorial, Fundraiser, Special Donation or P.R.?
We will make a custom donation form and link for you, and send thank you's and acknowledgement cards. We list donors and events in our website and newsletter. Please help raise awareness of scleroderma and related illnesses by mentioning the nonprofit International Scleroderma Network at sclero.org in conversations, speeches, web sites, and publications.
Thank you for helping us tackle scleroderma worldwide!
© Copyright 1998-2008 International Scleroderma Network
All Rights Reserved